Nalaganje...
Exploiting invariant NKT cells to promote T-cell responses to cancer vaccines
Invariant natural killer T (iNKT) cells have the capacity to amplify adaptive immune responses by licensing antigen-presenting cells. A simple vaccine consisting of whole tumor cells pulsed with an iNKT-cell agonist efficiently delivers antigens plus adjuvants to endogenous dendritic cells and has p...
Shranjeno v:
Main Authors: | , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Landes Bioscience
2013
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3654595/ https://ncbi.nlm.nih.gov/pubmed/23734325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.23789 |
Oznake: |
Označite
Brez oznak, prvi označite!
|